Fundraising Fox
/People
Sign in

Florian Denis

Investor

Partner at Elaia

Paris, France

Writes $100K – $5M checks · typically $1.5M

Find your path to Florian

139 people in our graph can introduce you to Florian.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Martine Caroff to introduce you to Florian

You →Martine · together at Hephaistos-Pharma (2024–2026) →Florian

Ask Jamie Chen to introduce you to Florian

You →Jamie · 2 people · together at Hephaistos-Pharma →Florian

Ask Sam Okafor to introduce you to Florian

You →Sam · 9 people · together at Elaia →Florian

Sign up to find every way you can get introduced to Florian

  • Your email: the people you already email who know Florian
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Florian
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Florian Denis is a scientifically conversant investor—serving on HEPHAISTOS‑Pharma’s board, offering mechanism-level immunology and clinical strategy guidance, and applying a repeatable early-stage-to-acquisition playbook proven by Gleamer and Mablink exits.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechCleantechCybersecurityDeep TechHardwareHealthtechMedical DevicesSaaS

Experience

  1. ElaiaPartnercurrent2025 — presentParis, Île-de-France, France
  2. ElaiaInvestment Director2021 — 2025Paris, Île-de-France, France
  3. ElaiaInvestment Manager2019 — 2021Paris Area, France
  4. BIOPHTABoard Membercurrent2024 — present
  5. HEPHAISTOS-PharmaBoard Membercurrent2024 — present
  6. GLEAMERBoard Membercurrent2021 — presentParis, Île-de-France, France
  7. Mablink BioscienceBoard Member2021 — 2023Lyon, Auvergne-Rhône-Alpes, France
  8. Société de Bourse Gilbert DupontEquity Research Analyst2019Paris Area, France
  9. VitaDXSupervisory Board Member2017 — 2019Paris Area, France
  10. TheranexusBoard Member2017 — 2019
  11. AurigaLife Sciences Associate2015 — 2019Région de Paris, France

Skills & more

Biotechnology16Lifesciences9

Languages English

From Florian's professional profile.

Colleagues at Elaia

Alexis Frentz
Investment Director at Elaia
Anne Bouverot
Independent Board Member at Elaia
Anne-Sophie Carrese
Managing Partner at Elaia
Anya Brochier
Marketing & Communications Senior Associate at Elaia
Arthur Liabastre
Senior Finance Officer at Elaia
Arturo Ancira García
Associate at Elaia
Camille Hamon
Finance Team Manager at Elaia
Cedric Favier
Early stage VC & entrepreneur at Elaia

Network5

Alexis Frentz
Investment Director at Elaia
Amélie Juge
Associate at Elaia
Anne-Sophie Carrese
Managing Partner at Elaia
Armelle de Tinguy
Partner at 115K
Celine Passedouet
Investment Director at Elaia

Investors connected to Florian in public investor directories — a warm-intro map.

Frequently asked questions

Who is Florian Denis?
Florian Denis is a scientifically conversant investor—serving on HEPHAISTOS‑Pharma’s board, offering mechanism-level immunology and clinical strategy guidance, and applying a repeatable early-stage-to-acquisition playbook proven by Gleamer and Mablink exits.
Where does Florian Denis work?
Florian Denis is Partner at Elaia.
What does Florian Denis invest in?
Florian Denis invests in AI & Machine Learning, Biotech, Cleantech, Cybersecurity, Deep Tech, Hardware, Healthtech, Medical Devices, SaaS.
What check size does Florian Denis write?
Florian Denis typically writes checks of $100K – $5M.
Where did Florian Denis go to school?
Florian Denis studied at Université Paris Dauphine - PSL (Master of Science (M.Sc.), Management de la Technologie et de l'Innovation (MTI)); SupBiotech, école de biotechnologies (Master's degree, Biotechnology); University of Essex.

Same school

Shared employers

Also worked at Société de Bourse Gilbert Dupont1

Mickael Chane-DuPartner at Olive Tree Capital